Over-expression of hsa_circ_0088214 suppresses tumor progression by inhibiting Akt signaling pathway in osteosarcoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37237370.
- Also identified by DOI 10.1186/s13018-023-03873-8 and PMC identifier 10214608.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
To explore the effect of has_circ_0088214 in osteosarcoma cells and corresponding mechanisms. Osteosarcoma cell line MG63 and U2OS were selected in this study. Wound-healing and matrigel transwell assays were performed to detect migration and invasion capacities. CCK-8 assay was used to measure cell growth and cisplatin resistance. Cell apoptosis was observed by Hoechst 33342 staining after H<sub>2</sub>O<sub>2</sub> induce. Western Blot was used to detect protein expression level. The rescue experiments were also performed using an Akt activator SC79. Hsa_circ_0088214 was down-regulated in osteosarcoma cells compared to normal osteoblast cells. Over-expression of has_circ_0088214 significantly reduced osteosarcoma cells invasion, migration and resistance to cisplatin, but the apoptotic ratio was increased. The phosphorylation level of Akt could be regulated by hsa_circ_0088214, and rescue experiments proved Akt signaling pathway took part in above biological processes. Up-regulation of hsa_circ_0088214 suppresses invasion, migration, cisplatin resistance but promoting apoptosis induced by H<sub>2</sub>O<sub>2</sub> by inhibiting Akt signaling pathway in osteosarcoma.
Medical subject headings
- Osteosarcoma
- Bone Neoplasms